PharVision Advisers’s Ichor Holdings ICHR Stock Holding History

PharVision Advisers’s Portfolio ICHR Stock Details ICHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,273	Closed	-$331K	–	389
2024 Q4	$331K	Buy	+10,273	New	+$318K	0.28%	124

Other funds holding ICHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PharVision Advisers's ICHR Position: Q1 2025 in Review

PharVision Advisers sold out of Ichor Holdings (ICHR) in Q1 2025, closing a stake of 10,273 shares — an estimated $331K sold.

PharVision Advisers first reported a position in ICHR in Q4 2024 and held it in 1 quarter. The position peaked at $331K in Q4 2024. 187 funds tracked by Wall St. Rank hold ICHR as of Q1 2025.

PharVision Advisers reported no remaining Ichor Holdings position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 10,273 Ichor Holdings shares in Q1 2025, an estimated $331K.
PharVision Advisers first reported a position in Ichor Holdings in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Ichor Holdings position peaked at $331K in Q4 2024.
187 funds tracked by Wall St. Rank held Ichor Holdings as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.